DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Analyst recommendations
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty brokerages that are presently covering the stock, MarketBeat.com reports ...
The stock of Dexcom Inc (DXCM) has seen a 3.56% increase in the past week, with a 27.65% gain in the past month, and a -2.26% decrease in the past quarter. The volatility ratio for the week ...